SETD7
MOLECULAR TARGETSET domain containing 7, histone lysine methyltransferase
SETD7 (SET domain containing 7, histone lysine methyltransferase) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SETD7
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | morin | 4.28 | 71 |
| 2 | shikonin | 4.11 | 60 |
| 3 | sinefungin | 3.74 | 41 |
| 4 | Cyproheptadine | 2.08 | 7 |
| 5 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 0.69 | 1 |
| 6 | scutellarein | 0.69 | 1 |
About SETD7 as a Drug Target
SETD7 (SET domain containing 7, histone lysine methyltransferase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented SETD7 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SETD7 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.